Condition
Recurrent Ependymoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Recurrent Ependymoma clinical trials that are recruiting, at sites in 3 countries (most in United States (2), Netherlands (1), Switzerland (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Immunotherapy using personalized T cells for pediatric brain tumors
This study is testing a new treatment using personalized immune cells to help young children with certain brain tumors that haven't completely gone away after standard treatment.
-
Using ONC206 to treat newly diagnosed and recurrent brain tumors in children and young adults
This study is testing a new treatment called ONC206, alone or with radiation, to see if it can help children and young adults with newly diagnosed or recurring brain tumors feel better.
Related topics
Quick answers
How many Recurrent Ependymoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Netherlands (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.